Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

× No keyword cloud information.

12 in total

1. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.

Authors: D Colledge; G Civitico; S Locarnini; T Shaw
Journal: Antimicrob Agents Chemother Date: 2000-03 Impact factor: 5.191

Review 2. Tolerability of treatments for viral hepatitis.

Authors: A Gervais; N Boyer; P Marcellin
Journal: Drug Saf Date: 2001 Impact factor: 5.606

3. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.

Authors: L Stuyver; C Van Geyt; S De Gendt; G Van Reybroeck; F Zoulim; G Leroux-Roels; R Rossau
Journal: J Clin Microbiol Date: 2000-02 Impact factor: 5.948

4. Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.

Authors: Zhi-Ying Ou; Na Liu; Chang-Jie Chen; Gang Cheng; Yun-Shao He
Journal: J Clin Microbiol Date: 2005-11 Impact factor: 5.948

5. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.

Authors: Julien Delmas; Olivier Schorr; Catherine Jamard; Craig Gibbs; Christian Trépo; Olivier Hantz; Fabien Zoulim
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

6. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.

Authors: F Le Guerhier; C Pichoud; C Jamard; S Guerret; M Chevallier; S Peyrol; O Hantz; I King; C Trépo; Y C Cheng; F Zoulim
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

7. Natural history and clinical management of chronic hepatitis B virus infection in children.

Authors: Mei-Hwei Chang
Journal: Hepatol Int Date: 2008-03-06 Impact factor: 6.047

Review 8. Clinical potential of emerging new agents in hepatitis B.

Authors: G C Farrell
Journal: Drugs Date: 2000-10 Impact factor: 9.546

Review 9. A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.

Authors: Fabien Zoulim
Journal: Drug Saf Date: 2002 Impact factor: 5.606

10. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.

Authors: A C Jacquard; M Nassal; C Pichoud; S Ren; U Schultz; S Guerret; M Chevallier; B Werle; S Peyrol; C Jamard; L T Rimsky; C Trepo; F Zoulim
Journal: Antimicrob Agents Chemother Date: 2004-07 Impact factor: 5.191